Company intelligence / Profile preview
TransTech Pharma
High Point, North Carolina, United Statesttpharma.com ↗
- Ownership
- Private
- Employees
- ~70
- Development stage
- Other
01
Overview
The company completed an End of Phase 2 meeting with the FDA for TTP488, but specific clinical results are not provided in the search results
- Modalities
- Small molecules
- Industry
- Biotech
02
Drug pipeline
1 asset03
Partnerships
Novo Nordisk A/SCephalon, Inc.SIGA TechnologiesWyeth-Ayerst LaboratoriesNational Institutes of Health
Beyond the preview
Go deeper on TransTech Pharma.
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Clinical trials
Follow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Licensing & deals
Explore licensing agreements, acquisitions, and the assets behind each deal.
- Partners
- Deal terms
- Milestones
Funding history
Trace financing activity and the investors behind a company’s development.
- Funding rounds
- Investors
- Capital raised
Competitive landscape
Compare peer pipelines by target, modality, and therapeutic area.
- Peer companies
- Targets
- Pipeline overlap
Technologies & patents
Explore technology platforms and the patent landscape around relevant assets.
- Platforms
- Patents
- Assignees
Research & analysis
Connect company news and source material to the questions you’re investigating.
- Company news
- Sources
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on TransTech Pharma.